Karnsakul Wikrom, Skitarelic Kathryn, Gillespie Stacey, Arkachaisri Thaschawee
Johns Hopkins University School of Medicine, Pediatrics, Baltimore, USA.
Turk J Gastroenterol. 2012;23(5):485-9. doi: 10.4318/tjg.2012.0317.
BACKGROUND/AIMS: The use of immunoglobulin G and A anti-gliadin antibodies for celiac disease screening has decreased due to higher specificity and sensitivity of tissue transglutaminase and endomysial antibodies. Greater values of immunoglobulin-A anti-gliadin antibody have been associated with more severe mucosal damage in proven and probable celiac disease patients. The aim of this study was to determine whether anti-gliadin antibody immunoglobulin A has any clinical importance in diagnosing celiac disease in children. Children with a chronic history of vomiting, abdominal pain, diarrhea, or constipation in the outpatient clinic were evaluated for celiac disease.
Tissue transglutaminase and anti-gliadin antibody immunoglobulin A in serum were determined by ELISA test and endomysial antibodies immunoglobulin A by indirect immunofluorescence. Most of these children with isolated positive anti-gliadin antibody immunoglobulin A were further evaluated by performing proximal gastrointestinal biopsies.
Sixteen children had isolated positive anti-gliadin antibody immunoglobulin A (negative tissue transglutaminase and endomysial antibodies immunoglobulin A). Eight were male (mean age: 9.7 years). None had immunoglobulin A deficiency. Thirteen underwent an upper endoscopy with multiple small bowel biopsies. Two patients had villous atrophy and slightly increased intraepithelial lymphocytes (Marsh 3a), which could make the diagnosis of celiac disease likely. These two patients had high titers of anti-gliadin antibody immunoglobulin A above 70 Units.
An isolated positive antigliadin antibody immunoglobulin A result in the absence of positive tissue transglutaminase and endomysial antibodies immunoglobulin A should raise the suspicion of the diagnosis of celiac disease. This could be a non-specific phenomenon that could be found in other gastrointestinal conditions, latent celiac disease, or gluten hypersensitivity. A longitudinal clinical follow-up is recommended in these children to confirm the diagnosis.
背景/目的:由于组织转谷氨酰胺酶和肌内膜抗体具有更高的特异性和敏感性,用于乳糜泻筛查的免疫球蛋白G和A抗麦醇溶蛋白抗体的使用已减少。在确诊和疑似乳糜泻患者中,免疫球蛋白A抗麦醇溶蛋白抗体的较高值与更严重的黏膜损伤相关。本研究的目的是确定抗麦醇溶蛋白抗体免疫球蛋白A在诊断儿童乳糜泻中是否具有任何临床意义。对门诊有慢性呕吐、腹痛、腹泻或便秘病史的儿童进行乳糜泻评估。
通过酶联免疫吸附测定法测定血清中的组织转谷氨酰胺酶和抗麦醇溶蛋白抗体免疫球蛋白A,通过间接免疫荧光法测定肌内膜抗体免疫球蛋白A。大多数这些抗麦醇溶蛋白抗体免疫球蛋白A单独呈阳性的儿童通过进行近端胃肠道活检进一步评估。
16名儿童抗麦醇溶蛋白抗体免疫球蛋白A单独呈阳性(组织转谷氨酰胺酶和肌内膜抗体免疫球蛋白A为阴性)。8名男性(平均年龄:9.7岁)。无人有免疫球蛋白A缺乏症。13人接受了上消化道内镜检查并进行了多次小肠活检。2例患者有绒毛萎缩和上皮内淋巴细胞略有增加(马什3a型),这可能使乳糜泻的诊断成立。这2例患者抗麦醇溶蛋白抗体免疫球蛋白A滴度高,高于70单位。
在组织转谷氨酰胺酶和肌内膜抗体免疫球蛋白A均为阴性的情况下,抗麦醇溶蛋白抗体免疫球蛋白A单独呈阳性结果应引起对乳糜泻诊断的怀疑。这可能是一种非特异性现象,可在其他胃肠道疾病、潜在乳糜泻或麸质超敏反应中发现。建议对这些儿童进行纵向临床随访以确诊。